獣医皮膚科用医薬品の世界市場レポート 2024年

獣医皮膚科用医薬品の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.5%の年間複合成長率（CAGR）で134億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、ペット保険の採用の増加、動物のアレルギー発生率の増加、ペット製品の世界化、ペットケアへの総合的なアプローチ、ペットの成長など、いくつかの要因に起因すると考えられます。動物の数、消費者教育の増加。予測期間中に予想される注目すべき動向には、獣医皮膚科学調査の進歩、アレルギー管理への注目の高まり、局所治療の需要の増大、栄養補助食品と皮膚科学的健康の交差点、獣医皮膚科における遠隔医療の統合、カスタマイズおよび個別化された医療の出現が含まれます。ペットへのヘルスケア支出の増加と相まって、ペット保険の導入が増加しています。

獣医皮膚科用医薬品市場の成長は、ペットの飼い主の数の増加によって促進されると予想されます。ペットの飼い主、つまりペットの動物を所有または引き取る個人は、ペットの健康と幸福を確保する上で重要な役割を果たします。この責任感の高まりにより、動物用医薬品の需要が増加します。 2021年に米国動物虐待防止協会（ASPCA）が実施した全国世論調査では、COVID-19危機の初期から猫または犬を飼っていた世帯が5世帯に1世帯（2,300万世帯）であることが明らかになった。特に、犬の90%と猫の85%が引き取った家に残り、各家庭がペットを引き留めることに熱心な姿勢を示しました。ペットの飼い主の数の増加が、獣医皮膚科用医薬品市場の主要な原動力となっています。

皮膚科疾患の負担の増加は、獣医皮膚科用医薬品市場の成長に大きく寄与すると予想されます。皮膚疾患には、遺伝学、環境要素、アレルギー、感染症、動物のライフスタイルの変化などの要因の影響を受ける、皮膚に影響を及ぼす幅広い病状が含まれます。飼い主は、動物の健康の重要性を認識しており、皮膚科的問題について獣医師によるケアを求めることが増えています。さらに、動物と人間の間で伝染する可能性のある人獣共通感染症に対する意識が高まり、動物の皮膚疾患の管理と治療の重要性が強調されています。一例として、2022年 10月、英国放送協会の報道では、インドの240万頭以上の動物に対するしこり状皮膚疾患の影響が強調され、11万頭以上の牛が死亡しました。皮膚科疾患の負担の増加は、獣医皮膚科用医薬品市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の獣医皮膚科用医薬品市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗真菌薬
• 抗菌薬
• 駆虫薬
• 世界の獣医皮膚科用医薬品市場、動物タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• コンパニオンアニマル
• 家畜
• 世界の獣医皮膚科用医薬品市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 外用
• 注射
• 経口
• 世界の獣医皮膚科用医薬品市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 小売り
• 病院薬局
• オンライン

第7章 地域および国の分析

• 世界の獣医皮膚科用医薬品市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の獣医皮膚科用医薬品市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医皮膚科用医薬品市場の競合情勢
• 獣医皮膚科用医薬品市場の企業プロファイル
  • Elanco Animal Health Inc.
  • Merk &Co. Inc.
  • Zoetis Inc.
  • Vetoquinol SA
  • Ceva Sante Animale

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Veterinary Dermatology Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary dermatology drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product Type: Antifungal Drugs; Antibacterial Drugs; Antiparasitic Drugs
• 2) By Animal Type: Companion Animal; Livestock Animal
• 3) By Drug Indication: Parasitic Infections; Allergic Infections; Other Indications
• 4) By Route of Administration: Topical; Injectable; Oral
• 5) By Distribution Channel: Retail; Hospital Pharmacies; Online
• Companies Mentioned: Elanco Animal Health Inc.; Merk & Co. Inc.; Zoetis Inc.; Vetoquinol SA; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Veterinary dermatology drugs encompass medications designed for the treatment of dermatological disorders in animals afflicted with skin conditions, including bacterial and fungal infections.

The primary categories of veterinary dermatology drugs include antifungal drugs, antibacterial drugs, and antiparasitic drugs. Antifungals are pharmaceuticals that inhibit the growth of fungi responsible for infections commonly affecting the skin, hair, and nails of animals. These drugs are administered through various routes, including topical, injectable, and oral methods. The target recipients of these medications are diverse, ranging from companion animals to livestock. The drugs are utilized for indications such as parasitic infections and allergic reactions. Distribution channels for veterinary dermatology drugs encompass retail outlets, hospital pharmacies, and online platforms.

The veterinary dermatology drugs market research report is one of a series of new reports from The Business Research Company that provides veterinary dermatology drugs market statistics, including veterinary dermatology drugs industry global market size, regional shares, competitors with a veterinary dermatology drugs market share, detailed veterinary dermatology drugs market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary dermatology drugs industry. This veterinary dermatology drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $7.75 billion in 2023 to $8.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The expansion observed in the historical period can be attributed to several factors, including the prevalence of dermatological conditions in animals, a rise in veterinary spending, changing environmental factors, increased awareness of companion animal healthcare, regulatory approvals, and heightened awareness of zoonotic diseases.

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $13.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing adoption of pet insurance, a rise in the incidence of allergies among animals, the globalization of pet products, a holistic approach to pet care, the growth of the companion animal population, and increased consumer education. Noteworthy trends expected in the forecast period encompass advancements in veterinary dermatology research, a heightened focus on allergy management, a growing demand for topical treatments, the intersection of nutraceuticals and dermatological health, the integration of telemedicine in veterinary dermatology, the emergence of customized and personalized therapies, and an increase in pet insurance adoption coupled with a rise in healthcare spending for pets.

The growth of the veterinary dermatology drugs market is anticipated to be propelled by the increasing number of pet owners. Pet owners, individuals who own or adopt pet animals, play a crucial role in ensuring the health and well-being of their pets. This heightened sense of responsibility results in an increased demand for veterinary drugs. In 2021, a national poll conducted by the American Society for the Prevention of Cruelty to Animals (ASPCA) revealed that one in five households had a cat or dog from the beginning of the COVID-19 crisis, constituting 23 million households. Notably, 90% of dogs and 85% of cats remained in their adopted homes, with households showing a commitment to retaining their pets. The growing number of pet owners is a key driver behind the veterinary dermatology drugs market.

The rise in the burden of dermatological diseases is expected to contribute significantly to the growth of the veterinary dermatology drugs market. Dermatological diseases encompass a broad spectrum of medical conditions affecting the skin, influenced by factors such as genetics, environmental elements, allergies, infections, and lifestyle changes in animals. Owners, recognizing the importance of their animals' well-being, are increasingly seeking veterinary care for dermatological issues. Additionally, the awareness of zoonotic diseases, which can be transmitted between animals and humans, emphasizes the importance of managing and treating skin conditions in animals. As an example, in October 2022, a report from the British Broadcasting Corporation highlighted the impact of lumpy skin disease on over 2.4 million animals in India, leading to the death of more than 110,000 cattle. The rising burden of dermatological diseases is a significant factor driving the growth of the veterinary dermatology drugs market.

In the pursuit of sustaining their market position, major companies in the veterinary dermatology drugs market are innovating by introducing new enzyme-based healthcare solutions. For instance, in October 2022, Pet King Brands Inc., a US-based pet care company, expanded its ZYMOX Enzymatic Dermatology product line with three new offerings specifically designed for cats and kittens. These products, featuring feline-centric packaging and the Seal of Endorsement from The International Cat Association (TICA), aim to address ear and skin conditions in felines without the use of antibiotics or harsh ingredients. The ZYMOX for Cats and Kittens range includes Enzymatic Ear Solution with 0.5% Hydrocortisone, Enzymatic Ear Cleanser, and Enzymatic Topical Cream with 0.5% Hydrocortisone. Leveraging the patented LP3 Enzyme System, these products offer effective solutions for common feline conditions such as ear infections, irritated skin, hot spots, ringworm, and acne.

Major players in the veterinary dermatology drugs market are strategically forming partnerships to broaden their offerings. Strategic partnerships involve companies combining their strengths and resources to achieve mutual benefits and success. For example, in January 2022, Dechra, a UK-based specialist in veterinary pharmaceuticals and related products, entered into a partnership with Bioiberica, a life science company specializing in veterinary pharmaceuticals. The collaboration involves the licensing and distribution of the Atopivet line of dermatological products for cats and dogs in the US, aiming to enhance the health and wellbeing of humans, animals, and plants.

In August 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company, completed the acquisition of Kindred Biosciences for a deal value of $444 million. This strategic move is expected to bolster and expedite Elanco's innovation, portfolio, and product strategy, enabling the company to provide veterinary solutions that address the unmet needs of pet owners. Kindred Biosciences, a US-based commercial-stage biopharmaceutical company focused on developing drugs for pets, operates in the veterinary dermatology drugs market.

Major companies operating in the veterinary dermatology drugs market report are Elanco Animal Health Inc., Merk & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Sante Animale, Virbac S.A., Bioiberica S.A.U., Bimeda Inc., Indian Immunologicals Ltd., Vivaldis Health and Fodds Pvt Ltd., IDEXX Laboratories Inc., Eli Lilly and Company, SavaVet, Toray Industries Inc., AB Science, Merial, Vetmedica, Mars Incorporated, Leti Pharma, Bioiberica S.A.U, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Kyoritsu Seiyaku Corporation, Veterinary Centers of America Inc., Heska Corporation, Biogenesis Bago, Nexvet, Aratana Therapeutics

North America was the largest region in the veterinary dermatology drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the veterinary dermatology drugs market report forecast period. The regions covered in the veterinary dermatology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary dermatology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary dermatology drugs market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Veterinary Dermatology Drugs Market Characteristics

3. Veterinary Dermatology Drugs Market Trends And Strategies

4. Veterinary Dermatology Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Veterinary Dermatology Drugs Market Size and Growth

• 5.1. Global Veterinary Dermatology Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Veterinary Dermatology Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Veterinary Dermatology Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Dermatology Drugs Market Segmentation

• 6.1. Global Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antifungal Drugs
• Antibacterial Drugs
• Antiparasitic Drugs
• 6.2. Global Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Companion Animal
• Livestock Animal
• 6.3. Global Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Topical
• Injectable
• Oral
• 6.4. Global Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retail
• Hospital Pharmacies
• Online

7. Veterinary Dermatology Drugs Market Regional And Country Analysis

• 7.1. Global Veterinary Dermatology Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Veterinary Dermatology Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Dermatology Drugs Market

• 8.1. Asia-Pacific Veterinary Dermatology Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Dermatology Drugs Market

• 9.1. China Veterinary Dermatology Drugs Market Overview
• 9.2. China Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Dermatology Drugs Market

• 10.1. India Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Dermatology Drugs Market

• 11.1. Japan Veterinary Dermatology Drugs Market Overview
• 11.2. Japan Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Dermatology Drugs Market

• 12.1. Australia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Dermatology Drugs Market

• 13.1. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Dermatology Drugs Market

• 14.1. South Korea Veterinary Dermatology Drugs Market Overview
• 14.2. South Korea Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Dermatology Drugs Market

• 15.1. Western Europe Veterinary Dermatology Drugs Market Overview
• 15.2. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Dermatology Drugs Market

• 16.1. UK Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Dermatology Drugs Market

• 17.1. Germany Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Dermatology Drugs Market

• 18.1. France Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Dermatology Drugs Market

• 19.1. Italy Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Dermatology Drugs Market

• 20.1. Spain Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Dermatology Drugs Market

• 21.1. Eastern Europe Veterinary Dermatology Drugs Market Overview
• 21.2. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Dermatology Drugs Market

• 22.1. Russia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Dermatology Drugs Market

• 23.1. North America Veterinary Dermatology Drugs Market Overview
• 23.2. North America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Dermatology Drugs Market

• 24.1. USA Veterinary Dermatology Drugs Market Overview
• 24.2. USA Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Dermatology Drugs Market

• 25.1. Canada Veterinary Dermatology Drugs Market Overview
• 25.2. Canada Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Dermatology Drugs Market

• 26.1. South America Veterinary Dermatology Drugs Market Overview
• 26.2. South America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Dermatology Drugs Market

• 27.1. Brazil Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Dermatology Drugs Market

• 28.1. Middle East Veterinary Dermatology Drugs Market Overview
• 28.2. Middle East Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Dermatology Drugs Market

• 29.1. Africa Veterinary Dermatology Drugs Market Overview
• 29.2. Africa Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Dermatology Drugs Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Dermatology Drugs Market Competitive Landscape
• 30.2. Veterinary Dermatology Drugs Market Company Profiles
  • 30.2.1. Elanco Animal Health Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merk & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Zoetis Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Vetoquinol SA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Ceva Sante Animale
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Veterinary Dermatology Drugs Market Competitive Benchmarking

32. Global Veterinary Dermatology Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Veterinary Dermatology Drugs Market

34. Veterinary Dermatology Drugs Market Future Outlook and Potential Analysis

• 34.1 Veterinary Dermatology Drugs Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Veterinary Dermatology Drugs Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Veterinary Dermatology Drugs Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer